{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:21:05Z","timestamp":1789698065992,"version":"4.0.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271"],"award-info":[{"award-number":["314061271"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bayerische Forschungsstiftung, Forschungsverbund FORTiTher","award":["AZ-1365-18"],"award-info":[{"award-number":["AZ-1365-18"]}]},{"name":"German Excellence Initiative to the Graduate School of Life Sciences"},{"DOI":"10.13039\/501100008769","name":"University of W\u00fcrzburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The dexamethasone suppression test (DST) is the recommended first-tier test for suspected Cushing syndrome (CS). Missed dexamethasone intake or insufficient dexamethasone serum exposure may yield false positive results. Quantification of serum dexamethasone in DST samples may therefore improve test performance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Simultaneous quantification of dexamethasone and cortisol by liquid chromatography-tandem mass spectrometry in 400 DST serum samples (100 overt CS, 200 excluded CS, 100 adrenal incidentalomas with (possible) autonomous cortisol secretion, AI-ACS) randomly selected within the indication groups. The 2.5th percentile of dexamethasone in patients with excluded CS was considered the lower limit of normal (LLN).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Serum dexamethasone varied from undetectable to 20.2\u2009ng\/mL with a median of 4.8\u2009ng\/mL (95% CI 4.5-5.1\u2009ng\/mL). Dexamethasone was undetectable in only 16 patients (4%), suggesting non-compliance. The dexamethasone LLN was 1.8\u2009ng\/mL (4.6\u2009nmol\/L). Decreased glomerular filtration rate and diabetes mellitus were associated with higher serum dexamethasone concentration, while body mass index, sex, age, nicotine, and oral contraceptives had no significant effect. By excluding the 27 samples with dexamethasone &amp;lt;LLN and applying the method-specific cortisol cutoff of 2.4\u2009\u00b5g\/dL (66\u2009nmol\/L) to samples with suspected CS, the clinical specificity for CS increased from 67.5% to 92.4% while preserving 100% clinical sensitivity. Among 100 AI-ACS samples (defined by immunoassay), 4 samples had dexamethasone &amp;lt;1.8\u2009ng\/mL and 14 samples had cortisol &amp;lt;2.4\u2009\u00b5g\/dL, which excluded autonomous cortisol secretion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Quantification of dexamethasone and method-specific cortisol cutoffs in DST samples may reduce the false positive rate and lower the proportion of patients requiring further workup.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/clinchem\/hvab056","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T11:07:39Z","timestamp":1617016059000},"page":"998-1007","source":"Crossref","is-referenced-by-count":39,"title":["Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome"],"prefix":"10.1093","volume":"67","author":[{"given":"Nora","family":"Vogg","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital W\u00fcrzburg, W\u00fcrzburg, Germany"},{"name":"Central Laboratory, Core Unit Clinical Mass Spectrometry, University Hospital W\u00fcrzburg, W\u00fcrzburg, German"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Kurlbaum","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital W\u00fcrzburg, W\u00fcrzburg, Germany"},{"name":"Central Laboratory, Core Unit Clinical Mass Spectrometry, University Hospital W\u00fcrzburg, W\u00fcrzburg, German"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Deutschbein","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital W\u00fcrzburg, W\u00fcrzburg, Germany"},{"name":"Medicover Oldenburg MVZ, Oldenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict","family":"Gr\u00e4sl","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital W\u00fcrzburg, W\u00fcrzburg, Germany"},{"name":"Central Laboratory, Core Unit Clinical Mass Spectrometry, University Hospital W\u00fcrzburg, W\u00fcrzburg, German"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7628-3161","authenticated-orcid":false,"given":"Matthias","family":"Kroiss","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital W\u00fcrzburg, W\u00fcrzburg, Germany"},{"name":"Central Laboratory, Core Unit Clinical Mass Spectrometry, University Hospital W\u00fcrzburg, W\u00fcrzburg, German"},{"name":"Department of Internal Medicine IV, LMU University Hospital Munich, University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"key":"2021070811023297400_hvab056-B1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"key":"2021070811023297400_hvab056-B2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: State of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2021070811023297400_hvab056-B3","doi-asserted-by":"crossref","first-page":"101380","DOI":"10.1016\/j.beem.2020.101380","article-title":"Cushing's syndrome: overview of clinical presentation, diagnostic tools and complications","volume":"34","author":"Barbot","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2021070811023297400_hvab056-B4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/a-0664-7632","article-title":"\"The adrenal gland: central relay in health and disease - current challenges and perspectives 2018\" - Cushing's disease","volume":"127","author":"Stalla","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2021070811023297400_hvab056-B5","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2021070811023297400_hvab056-B6","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1056\/NEJMc1705984","article-title":"Diagnosis and differential diagnosis of Cushing's syndrome","volume":"377","author":"Loriaux","year":"2017","journal-title":"N Engl J Med"},{"key":"2021070811023297400_hvab056-B7","doi-asserted-by":"crossref","first-page":"M33","DOI":"10.1530\/EJE-15-0464","article-title":"Cushing's syndrome: Update on signs, symptoms and biochemical screening","volume":"173","author":"Nieman","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2021070811023297400_hvab056-B8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3803\/EnM.2018.33.2.139","article-title":"Recent updates on the diagnosis and management of Cushing's syndrome","volume":"33","author":"Nieman","year":"2018","journal-title":"Endocrinol Metab"},{"key":"2021070811023297400_hvab056-B9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ecl.2018.02.001","article-title":"Diagnosis of Cushing's syndrome in the modern era","volume":"47","author":"Nieman","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2021070811023297400_hvab056-B10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/000456329703400302","article-title":"Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome\u2013recommendations for a protocol for biochemistry laboratories","volume":"34","author":"Wood","year":"1997","journal-title":"Ann Clin Biochem"},{"key":"2021070811023297400_hvab056-B11","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2021070811023297400_hvab056-B12","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1210\/js.2018-00382","article-title":"Adrenal hypercortisolism: a closer look at screening, diagnosis, and important considerations of different testing modalities","volume":"3","author":"Chiodini","year":"2019","journal-title":"J Endocr Soc"},{"key":"2021070811023297400_hvab056-B13","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing's syndrome: a consensus statement","volume":"88","author":"Arnaldi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2021070811023297400_hvab056-B14","first-page":"565","article-title":"The impact of dexamethasone pharmacokinetics on the DST: a review","volume":"27","author":"Guthrie","year":"1991","journal-title":"Psychopharmacol Bull"},{"key":"2021070811023297400_hvab056-B15","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1590\/S0004-27302007000800006","article-title":"Pitfalls in the diagnosis of Cushing's syndrome","volume":"51","author":"Vilar","year":"2007","journal-title":"Arq Bras Endocrinol Metab"},{"key":"2021070811023297400_hvab056-B16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2265.1982.tb00733.x","article-title":"Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone","volume":"16","author":"Meikle","year":"1982","journal-title":"Clin Endocrinol (Oxf)))"},{"key":"2021070811023297400_hvab056-B17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1192\/bjp.148.1.66","article-title":"Dexamethasone concentrations and the dexamethasone suppression test in psychiatric disorders","volume":"148","author":"Morris","year":"1986","journal-title":"Br J Psychiatry"},{"key":"2021070811023297400_hvab056-B18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0006-3223(96)00094-7","article-title":"Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects","volume":"41","author":"O'Sullivan","year":"1997","journal-title":"Biol Psychiatry"},{"key":"2021070811023297400_hvab056-B19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1530\/EC-12-0047","article-title":"Association between posttest dexamethasone and cortisol concentrations in the 1 mg overnight dexamethasone suppression test","volume":"1","author":"Asvold","year":"2012","journal-title":"Endocr Connect"},{"key":"2021070811023297400_hvab056-B20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1373\/clinchem.2007.100008","article-title":"Steroid hormone analysis by tandem mass spectrometry","volume":"55","author":"Soldin","year":"2009","journal-title":"Clin Chem"},{"key":"2021070811023297400_hvab056-B21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1472-6890-14-33","article-title":"Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction","volume":"14","author":"Krasowski","year":"2014","journal-title":"BMC Clin Pathol"},{"key":"2021070811023297400_hvab056-B22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1258\/acb.2011.011004","article-title":"Dexamethasone suppression test: development of a method for simultaneous determination of cortisol and dexamethasone in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"49","author":"Hempen","year":"2012","journal-title":"Ann Clin Biochem"},{"key":"2021070811023297400_hvab056-B23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-17-0078","article-title":"Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test","volume":"176","author":"Ueland","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2021070811023297400_hvab056-B24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/0004563218766566","article-title":"Development of a rapid liquid chromatography tandem mass spectrometry method for the quantitation of serum dexamethasone and its clinical verification","volume":"55","author":"Hawley","year":"2018","journal-title":"Ann Clin Biochem"},{"key":"2021070811023297400_hvab056-B25","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/0004563219870834","article-title":"Retrospective analysis of repeated dexamethasone suppression tests - the added value of measuring dexamethasone","volume":"56","author":"de Graaf","year":"2019","journal-title":"Ann Clin Biochem"},{"key":"2021070811023297400_hvab056-B26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s40618-020-01197-6","article-title":"Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation","volume":"43","author":"Ceccato","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"2021070811023297400_hvab056-B27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/clinchem\/17.4.275","article-title":"Influence of statistical method used on the resulting estimate of normal range","volume":"17","author":"Reed","year":"1971","journal-title":"Clin Chem"},{"key":"2021070811023297400_hvab056-B28","year":"2000"},{"key":"2021070811023297400_hvab056-B29","year":"2018"},{"key":"2021070811023297400_hvab056-B30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/avj.12818","article-title":"In this issue\u2013May 2019: West Nile virus in horses. Treating horses with dexamethasone via nebulisation. Animal hoarding in NSW. Dangers of powdered washing soda for emesis in dogs. Pneumocystis in a dog following toceranib phosphate. Oxalate nephrosis in koalas","volume":"97","author":"Jackson","year":"2019","journal-title":"Aust Vet J"},{"key":"2021070811023297400_hvab056-B31","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.clml.2020.06.022","article-title":"Comparative safety, bioavailability, and pharmacokinetics of oral dexamethasone, 4-mg and 20-mg tablets, in healthy volunteers under fasting and fed conditions: a randomized open-label, 3-way crossover study","volume":"20","author":"Bashir","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2021070811023297400_hvab056-B32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/EJE-14-0912","article-title":"ACTH after 15 min distinguishes between Cushing's disease and ectopic Cushing's syndrome: a proposal for a short and simple CRH test","volume":"173","author":"Ritzel","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2021070811023297400_hvab056-B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01059339","article-title":"Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics","volume":"9","author":"Rose","year":"1981","journal-title":"J Pharmacokinet Biopharm"},{"key":"2021070811023297400_hvab056-B34","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1210\/jc.2011-1565","article-title":"Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors","volume":"96","author":"Arlt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2021070811023297400_hvab056-B35","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S2213-8587(20)30218-7","article-title":"Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study","volume":"8","author":"Bancos","year":"2020","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/67\/7\/998\/38875327\/hvab056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/67\/7\/998\/38875327\/hvab056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T19:44:11Z","timestamp":1625773451000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/67\/7\/998\/6276574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,5,17]]},"published-print":{"date-parts":[[2021,7,6]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvab056","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2021,5,17]]}}}